Serve is a higher-beta way to express a view on physical AI and autonomous delivery robots.
Side-by-side research view
Compare names across metrics and research quality
Use up to 4 U.S.-listed names from this dashboard to compare valuation, growth, cash flow, balance-sheet strength, and the curated investment case in one place.
1 stocks in current compare
4 max names side by side
24 shared metrics lined up
Build a compare set
Enter comma-separated tickers from the dashboard universe. Duplicate tickers are ignored automatically.
Price
$8.86
1D change
-2.96%
Market cap
$670.6M
Sector
Industrials
| Metric | SERV |
|---|---|
| Price | $8.86 |
| 1D Change | -2.96% |
| Market Cap | $670.6M |
| Enterprise Value | $442.0M |
| Trailing P/E | — |
| Forward P/E | -5.5 |
| Price / Sales | 253.0 |
| EV / Revenue | 166.7 |
| Revenue Growth | 401.1% |
| Earnings Growth | — |
| Gross Margin | 0.0% |
| Operating Margin | -4410.7% |
| Net Margin | 0.0% |
| ROE | -42.0% |
| Free Cash Flow | $-77.6M |
| FCF Margin | -2928.7% |
| Debt / Equity | 1.50x |
| Current Ratio | 0.18x |
| Dividend Yield | — |
| Next Earnings | May 07, 2026 |
| Quarterly Revenue | $882.0K |
| Revenue QoQ | +28.4% |
| Quarterly Net Income | $-34.3M |
| Net Income QoQ | -3.8% |
SERV thesis lens
Autonomous delivery robotics
Why it could benefit
- Serve is a higher-beta way to express a view on physical AI and autonomous delivery robots.
- It adds a true early-stage robotics name to the sleeve rather than only mature industrial or medical platforms.
- If autonomous last-mile delivery scales, Serve could offer more upside torque than the larger incumbents.
Moat / edge
- A focused product around a clear real-world autonomy use case.
- Growing enterprise relationships and deployment history.
- Direct exposure to robot fleet growth rather than general automation spending.
What to watch
- Robot fleet growth, active deployments, and route economics.
- Partnership expansion and commercial traction.
- Cash burn and progress toward a sustainable operating model.
Key risks
- This is a speculative small-cap robotics name with execution risk.
- Commercial adoption and unit economics still need to prove out at scale.